PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

114 hedge funds and large institutions have $599M invested in Phathom Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
–
Holders Change %
0%
% of All Funds
1.66%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.15%
New
18
Increased
48
Reduced
21
Closed
17
Calls
$5.18M
Puts
$606K
Net Calls
+$4.57M
Net Calls Change
+$4.75M

Top Buyers

1
PCM
1
Portolan Capital Management
Massachusetts
$11.6M
2
Jennison Associates
2
Jennison Associates
New York
$28.4M
3
Morgan Stanley
3
Morgan Stanley
New York
$7.85M
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$15.2M
5
CC
5
Checkpoint Capital
California
$9.01M

Top Sellers

1
TPC
1
Takeda Pharmaceutical Company
Japan
$16M
2
OCA
2
Octagon Capital Advisors
New York
$0
3
6CM
3
683 Capital Management
New York
$14.4M
4
Millennium Management
4
Millennium Management
New York
$0
5
NM
5
Newtyn Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Principal Financial Group
126
Principal Financial Group
Iowa
– -$115K -10,783 Closed
MLICM
127
Metropolitan Life Insurance Company (MetLife)
New York
– -$19.3K -1,818 Closed
IGWM
128
ICA Group Wealth Management
Colorado
– -$13.8K -1,300 Closed
VI
129
Vestcor Inc
New Brunswick, Canada
– -$6K -548 Closed
AWM
130
Avior Wealth Management
Nebraska
– -$74 -7 Closed
2 3 4 5
6